MADISON, Wis., July 21, 2017 /PRNewswire/ -- Exact Sciences
Corp. (NASDAQ: EXAS) today announced that, in support of the
Company's continued growth plans, it granted restricted stock units
covering a total of 145,348 shares of common stock to 167 recently
hired non-executive employees under its previously announced
inducement grant program. The restricted stock unit awards vest in
four equal annual installments beginning on the first anniversary
of the grant date. The awards were granted as an inducement
material to the recently hired employees entering into employment
with the Company in accordance with NASDAQ Marketplace Rule
5635(c)(4). The Company is making this announcement as
required by NASDAQ rules.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused
on the early detection and prevention of the deadliest forms of
cancer. The company has exclusive intellectual property protecting
its non-invasive, molecular screening technology for the detection
of colorectal cancer. For more information, please visit the
company's website at www.exactsciences.com, follow Exact Sciences
on Twitter @ExactSciences or find Exact Sciences on Facebook.
This news release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
that are intended to be covered by the "safe harbor" created by
those sections. Forward-looking statements, which are based on
certain assumptions and describe our future plans, strategies and
expectations, can generally be identified by the use of
forward-looking terms such as "believe," "expect," "may," "will,"
"should," "could," "seek," "intend," "plan," "estimate,"
"anticipate" or other comparable terms. All statements other than
statements of historical facts included in this news release
regarding our strategies, prospects, financial condition,
operations, costs, plans and objectives are forward-looking
statements. Examples of forward-looking statements include, among
others, statements we make regarding expected future operating
results, anticipated results of our sales and marketing efforts,
expectations concerning payer reimbursement and the anticipated
results of our product development efforts. Forward-looking
statements are neither historical facts nor assurances of future
performance. Instead, they are based only on our current beliefs,
expectations and assumptions regarding the future of our business,
future plans and strategies, projections, anticipated events and
trends, the economy and other future conditions. Because
forward-looking statements relate to the future, they are subject
to inherent uncertainties, risks and changes in circumstances that
are difficult to predict and many of which are outside of our
control. Our actual results and financial condition may differ
materially from those indicated in the forward-looking statements.
Therefore, you should not rely on any of these forward-looking
statements. Important factors that could cause our actual results
and financial condition to differ materially from those indicated
in the forward-looking statements include, among others, the
following: our ability to successfully and profitably market our
products and services; the acceptance of our products and services
by patients and healthcare providers; our ability to meet demand
for our products and services; the willingness of health insurance
companies and other payers to cover Cologuard and reimburse us for
our performance of the Cologuard test; the amount and nature of
competition from other cancer screening products and services; the
effects of the adoption, modification or repeal of any healthcare
reform law, rule, order, interpretation or policy; the effects of
changes in healthcare pricing, coverage and reimbursement;
recommendations, guidelines and quality metrics issued by various
organizations such as the U.S. Preventive Services Task Force, the
American Cancer Society, and the National Committee for Quality
Assurance regarding cancer screening or our products and services;
our ability to successfully develop new products and services; our
success establishing and maintaining collaborative, licensing and
supplier arrangements; our ability to maintain regulatory approvals
and comply with applicable regulations; and the other risks and
uncertainties described in the Risk Factors and in Management's
Discussion and Analysis of Financial Condition and Results of
Operations sections of our most recently filed Annual Report on
Form 10-K and our subsequently filed Quarterly Report(s) on Form
10-Q. We undertake no obligation to publicly update any
forward-looking statement, whether written or oral, that may be
made from time to time, whether as a result of new information,
future developments or otherwise.
Contact:
J.P. Fielder
Senior Director, Corporate Communications, Exact Sciences Corp.
608-210-5220
jpfielder@exactsciences.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/exact-sciences-grants-inducement-restricted-stock-unit-awards-to-recently-hired-employees-300492386.html
SOURCE EXACT SCIENCES CORP